Hepatobiliary Surgery and Nutrition

Article	Citations
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights	256
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma	94
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)	58
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional O	46
Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma	44
International expert consensus on laparoscopic pancreaticoduodenectomy*	42
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?	41
Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes	38
Neuroendocrine liver metastases: a contemporary review of treatment strategies	35
Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians	30
Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection	26
Optimization of the future remnant liver: review of the current strategies in Europe	26
Biliary complications after liver transplantation: current perspectives and future strategies	26
A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	25
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy	24
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights	24
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease	23
Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma	22
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients	21
When a new definition overhauls perceptions of MAFLD related cirrhosis care	20
Diagnosis-related Groups (DRG) pricing and payment policy in China: where are we?	20
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients	19
Cholangiocarcinoma: a review of the literature and future directions in therapy	19
An overview of the Chinese healthcare system	18
The beneficial effects of intermittent fasting: an update on mechanism, and the role of circadian rhythm and gut microbiota	16

Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need	16
Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses	15
The gut-liver axis as a target of liver disease management	15
Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores	14
Machine learning predicts unpredicted deaths with high accuracy following hepatopancreatic surgery	13
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice	13
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	13
Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex	12
The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study	12
Liver venous deprivation: a bright future for liver metastases—but what about hepatocellular carcinoma?	12
Artificial intelligence is poised to revolutionize human liver allocation and decrease medical costs associated with liver transplantation	11
Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis	11
PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver	11
Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study	11
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?	11
How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue p	11
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future	11
Combination immunotherapy with anti-VEGF/TKI for hepatocellular carcinoma: present and future perspective	10
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity	10
A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus	10
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen	10
Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?	9
The internet hospital: how to combine with traditional healthcare model	9
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries	9
Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions	9
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus	9
New-onset diabetes after adult liver transplantation in the Korean Organ Transplantation Registry (KOTRY) study	9
Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis	9
Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review	8
The socioeconomic aspects of nonalcoholic fatty liver disease: food insecurity as a novel risk factor for steatosis and liver fibrosis	8
Gallbladder volvulus	8
Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a mul	8
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review	8
Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma	8
Surgery for pancreatic cancer: recent progress and future directions	8
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection	8
Robotic-assisted versus open total pancreatectomy: a propensity score-matched study	8
The upward trend in the immunotherapy utilization for hepatobiliary cancers	7
Perihilar-cholangiocarcinoma: what really matters?	7
Conversion surgery for hepatocellular carcinoma in the new era of targeted and immune checkpoint inhibitor therapies	7
The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)	7
Hepatic artery reconstruction technique in liver transplantation: experience with 3,000 cases	7
SARS-CoV-2 and liver damage: a possible pathogenetic link	7
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	7
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma	7
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?	7
A narrative review of the current and future role of robotic surgery in liver surgery and transplantation	7
Mediterranean diet as the ideal model for preventing non-alcoholic fatty liver disease (NAFLD)	7
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection	7
Non-alcoholic fatty liver disease (NAFLD) diagnosis and management—differentiating the essential from the ancillary and the present from the future	6

Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation	6
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice	6
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	6
Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change	6
Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review	6
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	6
Automated liver tumor detection in abdominal ultrasonography with a modified faster region-based convolutional neural networks (Faster R-CNN) architecture	6
Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma	6
Expert consensus on difficult airway assessment	6
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice	6
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients	6
Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI)	6
Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation	5
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study	5
Comparative long-term outcomes for pancreatic volume change, nutritional status, and incidence of new-onset diabetes between pancreatogastrostomy and pancreatojejunostomy after pancreaticoduodenectomy	5
No touch radiofrequency ablation for hepatocellular carcinoma: a conceptual approach rather than an iron law	5
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatoc	5
Revisiting human liver anatomy: dynamic watershed theory	5
The beneficial impacts of splanchnic vasoactive agents on hepatic functional recovery in massive hepatectomy porcine model	5
Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation	5
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study	5
Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents	5
Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: new insights from subcutaneous semaglutide	5
Limited potential of resolvin D1 in treatment of cholestatic liver fibrosis	5
Use of imaging as staging and surgical planning for pancreatic surgery	5
Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease	5
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid	5
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma	4
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma	4
Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable	4
Prospective study to evaluate the prognostic value of different nutritional assessment scores in liver surgery: NURIMAS Liver (DRKS00006340)	4
Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?	4
Uncommon indications for associating liver partition and portal vein ligation for staged hepatectomy: a systematic review	4
Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis	4
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection	4
Clinical implications of the dual blockade of the PD-1/PD-L1 and vascular endothelial growth factor axes in the treatment of hepatocellular carcinoma	4
Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases	4
Addressing the variation in hepatic surgery for colorectal liver metastasis	4
Semaglutide for nonalcoholic steatohepatitis: closer to a solution?	4
The future of robotic liver surgery	4
Understanding traditional Chinese medicine	4
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	4
Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma	4
Nonalcoholic fatty liver disease in type 2 diabetes: awareness is the first step toward change	4
New guidelines for the treatment of severe acute pancreatitis	4
Not yet IDEAL?—evidence and learning curves of minimally invasive pancreaticoduodenectomy	4
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis	4
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	4
Gut microbiota and hepatocellular carcinoma	4
Stool banking for fecal microbiota transplantation: ready for prime time?	4
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up	4
Editorial comment: a review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	4
A comparative study of pancreas transplantation between type 1 and 2 diabetes mellitus	3
The role of the robot-assisted procedure during total pancreatectomy: a viewpoint	3
Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy	3
Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)	3
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality	3
The potential use of extended criteria donors and eligible recipients in liver transplantation for unresectable colorectal liver metastases in Central Sweden	3
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections	3
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	3
The benefit of curative liver resection with a selective bile duct preserving approach for hepatocellular carcinoma with macroscopic bile duct tumor thrombus	3
Improvement and development in anatomical hepatectomy for hepatocellular carcinoma	3
A female surgeon’s thoughts on gender attributes in surgery	3
Portal inflow reconstruction for liver transplantation with portal vein thrombosis	3
An important measure taken for China Organ Transplant Response System	3
Laparoscopic surgery for colorectal liver metastases: moving forward while keeping feet on the ground	3
Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis	3
Functional assessment of liver regeneration after major hepatectomy	3
Validation of the Enhanced Recovery after Surgery (ERAS) society recommendations for liver surgery: a prospective, observational study	3
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection	3
Launching of the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in the Sultanate of Oman to manage HBP type of cancers	3
Roles of the human microbiome in cancer	3
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021	3
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma	3
Emergency laparoscopic pancreatoduodenectomy as treatment for pancreatic head cancer-induced acute gastrointestinal hemorrhage, safe or not?	3
Synchronous colorectal liver metastases: therapeutic considerations	3
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals	3
Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma—a cost-effectiveness analysis	3
A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy—the Hepatectomy Risk Score (HeRS)	3
Vessels encapsulating tumor clusters in hepatocellular carcinoma: a unique and valuable pathological imaging	3

Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: Insights next generation sequencing	3
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk	3
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma	3
Current status of treatment for colorectal liver metastases in the United Kingdom	3
Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)	3
Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China	3
Robotic pancreaticoduodenectomy after the learning curve—a new hope	3
Liver transplantation for unresectable colorectal metastasis: a new hope	3
The challenge of hepatic vein reconstruction in surgical oncology	3
Challenges in elucidating cholangiocarcinoma etiology	3
Management of recurrent hepatocellular carcinoma after resection	3
Inflammation is king in liver resection for hepatocellular carcinoma	3
Have we really understood when the efforts of laparoscopic liver resection are justified?—a complexity-based appraisal of the differential benefit	3
Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients—medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers	3
Screening for pancreatic cancer—a compelling challenge	3
Pan-peroxisome proliferator-activated receptor agonist lanifibranor as a dominant candidate pharmacological therapy for nonalcoholic fatty liver disease	2
Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions	2
Refining selection criteria to further increase survival benefit in liver transplantation for unresectable colorectal liver metastases	2
Finding a role for cancer vaccines in pancreatic cancer: a model of resilience	2
The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?	2
Comment on: simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases	2
NAFLD or MAFLD: the data behind the debate	2
Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?	2
Conversion therapy of stage IVb unresectable gallbladder carcinoma	2
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis	2
Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis	2
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?	2
Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?—Still an unsolved question	2
The 11th revision of the International Statistical Classification of Disease and Related Health Problems and Cholangiocarcinoma	2
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease	2
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score: is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged h	2
Predicting post-operative pancreatic fistula: one size may not fit all	2
How to balance the development of new surgical techniques and protection of patients’ health interests	2
Comment on: Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients	2
Can robotic liver resection compensate for weaknesses of the laparoscopic approach?	2
A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma	2
Nutritional management after hepatopancreatobiliary surgery	2
Prognosis control surgery	2
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience	2
The rapidly expanding role of thermal ablation in the treatment of colorectal liver metastases	2
Impact of nutritional status on outcome of pancreatic resections for pancreatic cancer and periampullary tumors	2
Advances in 3D bioprinting technology for liver regeneration	2
Time to rebuild the doctor-patient relationship in China	2
Is robotic pancreatic surgery finally ready for prime-time?	2
A haemorrhagic cholecystitis presenting as obstructive jaundice	2
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	2
Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection?	2
Does laparoscopic resection for colorectal cancer liver metastasis have a long-term oncologic advantage?	2
Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?	2
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	2
The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A	2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment	2
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	2
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus	2
French editorial from the ACHBPT: blood salvage and autotransfusion during liver transplantation for advanced hepatocellular carcinoma	2
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery	2
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?	2
Retrospective analysis of 45 cases of localized retroperitoneal Castleman disease from a single center	2
Liver segment 2+3 living donation in liver transplantation for colorectal liver metastases	2
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	2
Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient	2
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice	2
Expert consensus on magnetic recanalization technique for biliary anastomotic strictures after liver transplantation	2
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	2
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT	2
Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease	2
Liver cirrhosis and sarcopenia: a dreadful combination	2
Dietary health of medical workers: who’s taking care of it?	2
Tailoring bacterial taxa for immune cell modulation	2
Three-dimensional bioprinted liver tissue for transplantation: hope or hype?	2
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases	2
Age-specific microbiota in altering host inflammatory and metabolic signaling and metabolome based on sex	2
The role of associating liver partition and portal vein ligation for staged hepatectomy in the management of patients with colorectal liver metastasis	2
Clinical impact of omega-3 fatty acids (Ω3 FA) supplementation on liver surgery	2
The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study	2
Pediatric NAFLD: lessons from the gut	2